Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03927371
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
C6L | N-hexanoyl-L-homoserine | A | 3DHA | 0.79 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHB | 0.79 | |
CLG | 2-AMINO-6-[2-(2-AMINOOXY-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.71 | |
LNT | N-[(2S)-2-amino-1,1-dihydroxy-4- methylpentyl]-L-threonine | A,B,C | 3B80 | 0.75 | |
LNT | N-[(2S)-2-amino-1,1-dihydroxy-4- methylpentyl]-L-threonine | A,B,C | 3B7V | 0.75 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PPP | 0.8 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PE6 | 0.8 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1ITO | 0.8 | |
LAA | (3R)-3-hydroxy-L-alpha-asparagine | A | 1CCF | 0.74 | |
5FP | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID | A,B | 1XE6 | 0.72 | |
AHB | BETA-HYDROXYASPARAGINE | A | 1DSR | 0.71 | |
AHB | BETA-HYDROXYASPARAGINE | A,G | 1NT0 | 0.71 | |
AHB | BETA-HYDROXYASPARAGINE | A | 2ZGD | 0.71 | |
AHB | BETA-HYDROXYASPARAGINE | A,B | 2QC9 | 0.71 | |
AHB | BETA-HYDROXYASPARAGINE | A | 2OG7 | 0.71 | |
AN0 | N-ACETYL-L-NORVALINE | C,D,E,X,Y,Z | 2G7M | 0.71 | |
AN0 | N-ACETYL-L-NORVALINE | A | 1ZQ8 | 0.71 | |
074 | [PROPYLAMINO-3-HYDROXY-BUTAN-1,4- DIONYL]-ISOLEUCYL-PROLINE | A | 1QDQ | 0.73 | |
5FE | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID METHYL ESTER | A,B | 1XE5 | 0.71 | |
ATI | N-(3-AMINO-2-HYDROXY-5-METHYLHEXANOYL)VALYLVALYLASPARTIC ACID | A | 1Y0Y | 0.76 | |
C99 | {(2R)-2-[(1S,2R)-1-AMINO-2-HYDROXYPROPYL]- 2-HYDROXY-4,5-DIOXOIMIDAZOLIDIN- 1-YL}ACETIC ACID | A | 2HCG | 0.75 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1AEC | 0.72 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A,B | 2PRE | 0.72 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1CV8 | 0.72 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 3C9E | 0.72 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A,B | 3BCN | 0.72 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1ATK | 0.72 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A,B,C,D | 3BPF | 0.72 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1TLO | 0.72 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1QX6 | 0.72 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1MEG | 0.72 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A,B,C,D | 2BDZ | 0.72 | |
76V | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE | A | 2DCB | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B,K,L | 1B8D | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P,Q,R, S,T,U,V,W,X | 1GH0 | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D | 1XF6 | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, H,I,J,K,L,M | 1B33 | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B | 1I7Y | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B | 3BRP | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B | 1JBO | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B | 1ALL | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B,K,L | 1EYX | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P,Q,R, S,T,U,V,W,X | 1HA7 | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D | 2VJH | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B | 1KTP | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B | 1PHN | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D | 1QGW | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D | 1XG0 | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B | 2VJT | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, K,L,M,N,O,P | 2BV8 | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B | 2V8A | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, G,H | 3DBJ | 0.71 | |
DLS | DI-ACETYL-LYSINE | A,B,C,D,E,F | 1FVM | 0.7 | |
CLH | 2-AMINO-6-[2-(2-OXO-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.71 | |
75V | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE | A | 2DCA | 0.72 | |
042 | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-THREONYL-L-ISOLEUCINE | A | 2DC7 | 0.72 | |
6PR | (S)-4-AMINO-4-OXO-3-(2-PHOSPHONOACETAMIDO)BUTANOIC ACID | A,B,C,D | 2H3E | 0.72 |